Skip to content
healthcare.dev

KESIMPTA

NDC 0078-1007, ofatumumab, injection, solution, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-1007
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125326
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1007 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OFATUMUMAB20 mg/.4mL

Pharmacologic classes

CD20-directed Antibody Interactions [MoA]; CD20-directed Cytolytic Antibody [EPC]

Package NDCNDC-11Package
0078-1007-68000781007681 SYRINGE, GLASS in 1 CARTON (0078-1007-68) / .4 mL in 1 SYRINGE, GLASS
0078-1007-98000781007981 SYRINGE, GLASS in 1 CARTON (0078-1007-98) / .4 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6a8a3f53-2062-48ff-9dbe-b939df133ca3
  • NADAC price for package 00078100768

    GET /v1/drugs/nadac/00078100768

Use it

Look up 0078-1007 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1007 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-1007. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.